
MRK Stock Down 1% in Pre-market, Merck Halts Its Covid-19 Vaccine Development
Merck has a reported market valuation of approximately $204.88 billion with 2.53 billion outstanding shares. The company’s leadership has opted to commit its resources towards developing coronavirus therapy drugs.